{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:38:47Z","timestamp":1786653527088,"version":"build-2736575974"},"reference-count":55,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Health","award":["DK102716"],"award-info":[{"award-number":["DK102716"]}]},{"name":"National Institute of Health","award":["DK119728"],"award-info":[{"award-number":["DK119728"]}]},{"name":"National Institute of Health","award":["DK123704"],"award-info":[{"award-number":["DK123704"]}]},{"name":"National Institute of Health","award":["GM130457"],"award-info":[{"award-number":["GM130457"]}]},{"name":"National Institute of Health","award":["CA138313"],"award-info":[{"award-number":["CA138313"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The incidence of nonalcoholic fatty liver disease (NAFLD), or metabolic dysfunction-associated fatty liver disease (MAFLD), is increasing in adults and children. Unfortunately, effective pharmacological treatments remain unavailable. Single nucleotide polymorphisms (SNPs) in the patatin-like phospholipase domain-containing protein (PNPLA3 I148M) have the most significant genetic association with the disease at all stages of its progression. A roadblock to identifying potential treatments for PNPLA3-induced NAFLD is the lack of a human cell platform that recapitulates the PNPLA3 I148M-mediated onset of lipid accumulation. Hepatocyte-like cells were generated from PNPLA3\u2212\/\u2212 and PNPLA3I148M\/M-induced pluripotent stem cells (iPSCs). Lipid levels were measured by staining with BODIPY 493\/503 and were found to increase in PNPLA3 variant iPSC-derived hepatocytes. A small-molecule screen identified multiple compounds that target Src\/PI3K\/Akt signaling and could eradicate lipid accumulation in these cells. We found that drugs currently in clinical trials for cancer treatment that target the same pathways also reduced lipid accumulation in PNPLA3 variant cells.<\/jats:p>","DOI":"10.3390\/ijms25137277","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T12:58:42Z","timestamp":1719925122000},"page":"7277","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A PNPLA3-Deficient iPSC-Derived Hepatocyte Screen Identifies Pathways to Potentially Reduce Steatosis in Metabolic Dysfunction-Associated Fatty Liver Disease"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0260-3185","authenticated-orcid":false,"given":"Caren","family":"Doueiry","sequence":"first","affiliation":[{"name":"Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA"},{"name":"Medical Scientist Training Program, Medical University of South Carolina, Charleston, SC 29425, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9197-4129","authenticated-orcid":false,"given":"Christiana S.","family":"Kappler","sequence":"additional","affiliation":[{"name":"Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2930-998X","authenticated-orcid":false,"given":"Carla","family":"Martinez-Morant","sequence":"additional","affiliation":[{"name":"Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2507-7827","authenticated-orcid":false,"given":"Stephen A.","family":"Duncan","sequence":"additional","affiliation":[{"name":"Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Pouwels, S., Sakran, N., Graham, Y., Leal, A., Pintar, T., Yang, W., Kassir, R., Singhal, R., Mahawar, K., and Ramnarain, D. (2022). Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss. BMC Endocr. Disord., 22.","DOI":"10.1186\/s12902-022-00980-1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/archdischild-2019-318063","article-title":"Non-alcoholic fatty liver disease and childhood obesity","volume":"106","author":"Shaunak","year":"2021","journal-title":"Arch. Dis. Child."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmet.2019.12.002","article-title":"Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease","volume":"31","author":"Romeo","year":"2020","journal-title":"Cell Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","article-title":"Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets","volume":"10","author":"Gressner","year":"2006","journal-title":"J. Cell. Mol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.5604\/01.3001.0012.0916","article-title":"New Insights About Albumin and Liver Disease","volume":"17","author":"Carvalho","year":"2018","journal-title":"Ann. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/jcar.JCar_9_16","article-title":"Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis","volume":"16","author":"Ghouri","year":"2017","journal-title":"J. Carcinog."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000282101","article-title":"The effect of lifestyle changes in non-alcoholic fatty liver disease","volume":"28","author":"Centis","year":"2010","journal-title":"Dig. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/stem.2454","article-title":"Concise Review: Current Status and Future Directions on Research Related to Nonalcoholic Fatty Liver Disease","volume":"35","author":"Wruck","year":"2017","journal-title":"Stem Cells"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"9521","DOI":"10.1073\/pnas.1901974116","article-title":"Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis","volume":"116","author":"BasuRay","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ijo.2009.216","article-title":"Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent","volume":"34","author":"Romeo","year":"2010","journal-title":"Int. J. Obes."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/hep.29298","article-title":"Mutant PNPLA3 I148M protein as pharmacological target for liver disease","volume":"66","author":"Valenti","year":"2017","journal-title":"Hepatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jcb.27378","article-title":"PNPLA3 variant M148 causes resistance to starvation-mediated lipid droplet autophagy in human hepatocytes","volume":"120","author":"Negoita","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"48968","DOI":"10.1074\/jbc.M407841200","article-title":"Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities","volume":"279","author":"Jenkins","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cmet.2012.04.008","article-title":"Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase","volume":"15","author":"Kumari","year":"2012","journal-title":"Cell Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"37085","DOI":"10.1074\/jbc.M111.290114","article-title":"Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease","volume":"286","author":"Huang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1194\/jlr.M011205","article-title":"Pnpla3\/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome","volume":"52","author":"Basantani","year":"2011","journal-title":"J. Lipid Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/hep.29273","article-title":"The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation","volume":"66","author":"BasuRay","year":"2017","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2022.08.022","article-title":"IL-6\/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver disease","volume":"78","author":"Park","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1002\/hep.32063","article-title":"Modeling PNPLA3-Associated NAFLD Using Human-Induced Pluripotent Stem Cells","volume":"74","author":"Tilson","year":"2021","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1053\/j.gastro.2021.02.050","article-title":"Induced Pluripotent Stem Cell-derived Hepatocytes From Patients With Nonalcoholic Fatty Liver Disease Display a Disease-specific Gene Expression Profile","volume":"160","author":"Duwaerts","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.stem.2017.01.011","article-title":"A Drug Screen using Human iPSC-Derived Hepatocyte-like Cells Reveals Cardiac Glycosides as a Potential Treatment for Hypercholesterolemia","volume":"20","author":"Cayo","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1242\/dev.146845","article-title":"A small-molecule screen reveals that HSP90\u03b2 promotes the conversion of induced pluripotent stem cell-derived endoderm to a hepatic fate and regulates HNF4A turnover","volume":"144","author":"Jing","year":"2017","journal-title":"Development"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.celrep.2018.10.036","article-title":"A Screen Using iPSC-Derived Hepatocytes Reveals NAD as a Potential Treatment for mtDNA Depletion Syndrome","volume":"25","author":"Jing","year":"2018","journal-title":"Cell Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/hep.30288","article-title":"The Use of Human Pluripotent Stem Cells for Modeling Liver Development and Disease","volume":"69","author":"Heslop","year":"2019","journal-title":"Hepatology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"109145","DOI":"10.1016\/j.celrep.2021.109145","article-title":"GATA6 defines endoderm fate by controlling chromatin accessibility during differentiation of human-induced pluripotent stem cells","volume":"35","author":"Heslop","year":"2021","journal-title":"Cell Rep."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Liu, J., Doueiry, C., Jiang, Y., Blaszkiewicz, J., Lamprecht, M., Heslop, J., Peterson, Y., Carten, J., Traktman, P., and Yuan, Y. (2023). A human iPSC-derived hepatocyte screen identifies compounds that inhibit production of Apolipoprotein B. Commun. Biol., 6.","DOI":"10.1038\/s42003-023-04739-9"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Si-Tayeb, K., Noto, F., Sepac, A., Sedlic, F., Bosnjak, Z., Lough, J., and Duncan, S. (2010). Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Dev. Biol., 10.","DOI":"10.1186\/1471-213X-10-81"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Salari, N., Darvishi, N., Mansouri, K., Ghasemi, H., Hosseinian-Far, M., Darvishi, F., and Mohammadi, M. (2021). Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: A systematic review and meta-analysis. BMC Endocr. Disord., 21.","DOI":"10.1186\/s12902-021-00789-4"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1G.4","DOI":"10.1002\/9780470151808.sc01g04s26","article-title":"Differentiation of hepatocytes from pluripotent stem cells","volume":"26","author":"Mallanna","year":"2013","journal-title":"Curr. Protoc. Stem Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.23354","article-title":"Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells","volume":"51","author":"Noto","year":"2010","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.stemcr.2016.07.016","article-title":"Mapping the Cell-Surface N-Glycoproteome of Human Hepatocytes Reveals Markers for Selecting a Homogeneous Population of iPSC-Derived Hepatocytes","volume":"7","author":"Mallanna","year":"2016","journal-title":"Stem Cell Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ceb.2004.03.003","article-title":"Nonsense-mediated mRNA decay: Terminating erroneous gene expression","volume":"16","author":"Baker","year":"2004","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","article-title":"Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids","volume":"30","author":"Ouchi","year":"2019","journal-title":"Cell Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12020-020-02470-7","article-title":"PNPLA3 I148M is involved in the variability in anti-NAFLD response to exenatide","volume":"70","author":"Chen","year":"2020","journal-title":"Endocrine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"STITCH 5: Augmenting protein-chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.breast.2022.03.018","article-title":"The emerging role of capivasertib in breast cancer","volume":"63","author":"Andrikopoulou","year":"2022","journal-title":"Breast"},{"key":"ref_38","first-page":"451","article-title":"Bosutinib: A novel src\/abl kinase inhibitor for chronic myelogenous leukemia","volume":"4","author":"Steinbach","year":"2013","journal-title":"J. Adv. Pract. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1091\/mbc.10.6.1693","article-title":"Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways","volume":"10","author":"Penuel","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Hatton, O., Lambert, S., Krams, S., and Martinez, O. (2012). Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042610"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1002\/ptr.6486","article-title":"Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db\/db mice","volume":"33","author":"Yang","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1017\/S1751731116000380","article-title":"Effects of inhibiting PI3K-Akt-mTOR pathway on lipid metabolism homeostasis in goose primary hepatocytes","volume":"10","author":"Liu","year":"2016","journal-title":"Animal"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1038\/s41598-020-60210-3","article-title":"Increased mitochondrial and lipid metabolism is a conserved effect of Insulin\/PI3K pathway downregulation in adipose tissue","volume":"10","author":"Bettedi","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"15347354211073163","DOI":"10.1177\/15347354211073163","article-title":"Management of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia","volume":"21","author":"Goncalves","year":"2022","journal-title":"Integr. Cancer Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Parafati, M., Bae, S., Kirby, R., Fitzek, M., Iyer, P., Engkvist, O., Smith, D., and Malany, S. (2020). Pluripotent Stem Cell-Derived Hepatocytes Phenotypic Screening Reveals Small Molecules Targeting the CDK2\/4-C\/EBP\u03b1\/DGAT2 Pathway Preventing ER-Stress Induced Lipid Accumulation. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249557"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"22678","DOI":"10.1074\/jbc.M704213200","article-title":"Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance","volume":"282","author":"Choi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ajh.25792","article-title":"Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring","volume":"95","author":"Jabbour","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/1078-0432.CCR-16-0134","article-title":"A Phase Ib Study of Alpelisib (BYL719), a PI3K\u03b1-Specific Inhibitor, with Letrozole in ER+\/HER2- Metastatic Breast Cancer","volume":"23","author":"Mayer","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/jcph.1942","article-title":"Population Pharmacokinetics of Ipatasertib and Its Metabolite in Cancer Patients","volume":"61","author":"Yoshida","year":"2021","journal-title":"J. Clin. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"111321","DOI":"10.1016\/j.celrep.2022.111321","article-title":"Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice","volume":"40","author":"Kabbani","year":"2022","journal-title":"Cell Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nmeth902","article-title":"Feeder-independent culture of human embryonic stem cells","volume":"3","author":"Ludwig","year":"2006","journal-title":"Nat. Methods"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nbt1177","article-title":"Derivation of human embryonic stem cells in defined conditions","volume":"24","author":"Ludwig","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Nagaoka, M., Si-Tayeb, K., Akaike, T., and Duncan, S. (2010). Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum. BMC Dev. Biol., 10.","DOI":"10.1186\/1471-213X-10-60"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Liu, J., Lamprecht, M., and Duncan, S. (2018). Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery. J. Vis. Exp., e57194.","DOI":"10.3791\/57194-v"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/13\/7277\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:09:03Z","timestamp":1760108943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/13\/7277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":55,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["ijms25137277"],"URL":"https:\/\/doi.org\/10.3390\/ijms25137277","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,2]]}}}